All the Active Ingredient Drugs
Antivirals/HIV. Cabotegravir 200 mg/ml. Prolonged-release suspension for injection 400 mg/ 2 ml, 600 mg/3 ml
Initiation injection (600 mg) On the final day of current antiretroviral ther. or oral lead-in ther.,single 600 mg by IM inject. Rilpivirine inject. should be admin. at separate gluteal site at the same visit.
Continuation injection (400 mg) single 400 mg monthly by IM inject. Rilpivirine inject. should be admin. at separate gluteal site at the same visit. Pts may be given inject. up to 7 days before or after the date of the monthly 400 mg injection sched.
In combin. with rilpivirine injection, for the tmt.of HIV-1 infect. in adults who are virologically suppressed (HIV-1 RNA <50 copies/mL) on a stable antiretroviral regimen without present or past evidence of viral resist. to, and no prior virological fail. with agents of the NNRTI and INI class.
C/I: Concom. use with rifampicin, rifapentine, carbamazepine, oxcarbazepine, phenytoin or phenobarbital. Hypersens.
